Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2012-A00225-38 | Registry Identifier | IDRCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This program aims to understand the role of the subthalamic nucleus in the control of the movement in healthy humans and patients with Parkinson's disease, how the STN dysfunction contributes to akinesia and how the STN stimulation improves motor signs in PD patients .
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Frequency of subthalamic stimulation | Experimental | Comparison between healthy controls and PD patients (non-operable patients or who will be operated or already operated) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bilateral subthalamic stimulation | Procedure |
|
| Measure | Description | Time Frame |
|---|---|---|
| Firing rate of the subthalamic neurons | Changes in the neuronal activity of the STN before, during and after the execution of an arm movement | During surgery for bilateral STN stimulation |
| Measure | Description | Time Frame |
|---|---|---|
| Evoked related potentials of the STN | Local-field potentials recordings with DBS electrodes when performing the execution of an arm movement or gait initiation | 3-5 days after surgery for bilateral STN stimulation |
| Biomechanical parameters of gait initiation |
| Measure | Description | Time Frame |
|---|---|---|
| BOLD signal during fMRI | Changes in the BOLD signal during fMRI with virtual imagery of movement | 1 month before surgery |
| real-life assessment | recording using the percept device |
Inclusion criteria for patients who will be operated
Criteria for non-inclusion of Parkinsonian patients who will be operated
Selection criteria for non-operated patients
Criteria for non-inclusion of non-operated patients
Inclusion criteria for group 3 patients (already operated)
Criteria for non-inclusion of Parkinsonian patients (already operated)
Inclusion criteria for healthy subjects
Criteria for non-inclusion of healthy subjects
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marie-Laure Welter, MD, PhD | Contact | marielaure.welter@icm-institute.org | ||
| Carine Karachi, MD, PhD | Contact | carine.karachi@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Marie-Laure Welter, MD, PhD | GHPS, APHP, Paris, France | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Groupe Hospitalier Pitie-Salpêtrière | Recruiting | Paris | PARIS | 75013 | France |
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Gait initiation parameters by using a forceplate and EMG recordings |
| 6 months |
| 1 month after surgery |
| CIC-GHPS | Recruiting | Paris | 75013 | France |
|
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |